STAT Breakthrough Summit East​ 2024 | STAT | 21 March 2024 | Cure., 345 Park Ave S, New York, NY 10010, USA

New initiatives and all sorts of tools and technologies aim to improve the patient experience. Pharma and biotech companies claim to put the patient at the center of what they do. So, too, do research organizations.

But what does focusing on patients really mean? How should it shape an R&D effort? And how should patient voices shape regulation, commerce, and the practice of medicine? We’ll look at these questions broadly in biotech and health tech, gathering top experts, CEOs, and, of course, patients to come up with real, deliverable answers about how to make sure that science is benefitting the people who desperately need it.

2024 Speakers

MODERATORS:

Elaine Chen
Cardiovascular Disease Reporter, STAT

Allison DeAngelis
Biotech Startups and Venture Capital Reporter, STAT

Adam Feuerstein
Senior Writer, Biotech, STAT

Damian Garde
National Biotech Correspondent, STAT

Gideon Gil
Managing Editor, STAT

Matthew Herper
Senior Writer, Medicine; Editorial Director of Events, STAT

Usha Lee McFarling
National Science Correspondent, STAT

Megan Molteni
Science Writer, STAT

Ed Silverman
Pharmalot Columnist, Senior Writer, STAT

Nicholas St. Fleur
General Assignment Reporter; Associate Editorial Director of Events, STAT

SPONSOR SPEAKERS:

Reshema Kemps-Polanco
EVP and Chief Commercial Officer, US, Novartis

Tina Deignan, Ph.D.
SVP, TA Head Oncology, US, Novartis

Mohit Monrao
Senior Vice President, US Oncology Business, AstraZeneca

SPEAKERS:

Nora Volkow, M.D.
Director, National Institute on Drug Abuse

George Yancopoulos, M.D., Ph.D.
Board Co-Chair, Co-Founder, President and Chief Scientific Officer, Regeneron

Feng Zhang, Ph.D.
Core Member, Broad Institute of MIT and Harvard

Julia Vitarello
Mila’s Mom, Founder & CEO, Mila’s Miracle Foundation

Mikael Dolston M.D., Ph.D.
Chief Scientific Officer, President, Pfizer Research & Development

Utibe Essien, M.D
Assistant Professor of Medicine, UCLA

Kathy Giusti
Co-founder of the Multiple Myeloma Research Foundation and author of “Fatal to Fearless"

Cathy Collet
Independent ALS Advocate

Gregg Gonsalves, Ph.D.
Associate Professor, Yale School of Public Health

Ross Hoffman, M.D.
Former Chief Medical Officer, Pharmacy/Innovation, Centene Corporation; Board Member, Advisor and Investor

Xin Li, Ph.D.
Professor, New York University

Mathai Mammen, M.D., Ph.D.
CEO & Chairman, FogPharma

Jennifer McNary
Parent Advocate; Owner, Canary Advisors

Rod Nathan, M.D.
Portfolio Manager & Partner, J. Goldman & Co

Patrick Nosker
Director of Research and Partner, Affinity Asset Advisors, LLC

Fyodor Urnov, Ph.D.
Professor, UC Berkeley; Director, IGI-Danaher Beacon for CRISPR Cures

Ashley Valentine
President & Co-Founder, Sick Cells

Xin Zhang
Distinguished Professor of Engineering, Boston University

2024 Sponsors

PRESENTING SPONSOR:
• Novartis

PREMIUM SPONSOR:
• AstraZeneca

SUPPORTING SPONSOR:
• Bluebirdbio